Optimization of xanthan gum production by demerara sugar using response surface methodology

Xanthan gum (XG) production using three Xanthomonas sp. strains (290, 472, and S6) was evaluated by applying a 23 full factorial central composite design response to study the interactive effects of the fermentation medium component concentrations as parameters to determine the efficiency of the gum production in batch experiments. The experimental variables were the carbon source (demerara sugar or sucrose), potassium phosphate dibasic, and magnesium sulfate. Experimental results showed the K2HPO4 concentration as the important parameter for XG production by using Xanthomonas axonopodis pv. manihotis IBSBF 290 and X. campestris pv. campestris IBSBF 472, while for the Xanthomonas sp. S6 strain, the MgSO4∙7H2O concentration was the determining factor in XG production using demerara sugar or sucrose as a carbon source. The strains of Xanthomonas 472 and S6, using demerara sugar and higher concentrations of salts, exhibited a higher yield of XG (36 and 32%) than when using sucrose and the same concentration of salts. The experimental outcomes highlighted demerara sugar as a suitable and efficient alternative carbon and micronutrient source for XG production. Despite the bacterial strain influence, the medium composition is crucial for this fermentation process. Therefore, the evaluated salts are important factors for XG production, and the demerara sugar can partially replace this mineral salt requirement as indicated by the face-centered composite experimental design due to its chemical composition. Overall, demerara sugar provides promising properties for XG production.The authors acknowledge the financial assistance from the Brazilian research funding agencies including the Co-ordination for the Improvement of Higher Education Personnel (CAPES) under Finance Code 001, a Brazilian foundation within the Ministry of Education (MEC); the National Council for Scientific and Technological Development (CNPq), a Brazilian foundation associated to the Ministry of Science, Technology, and Innovations (MCTI); the Foundation of Support to Research and Technological Innovation of the State of Sergipe (FAPITEC/SE); and the Regional Co-operative of Agrarian Reform Settlers of Sergipe’s Semi-Arid. The authors acknowledge the Foundation for Science and Technology (FCT, Portugal) for the financial support to the CISAS UIDB/05937/2020 and UIDP/05937/2020, including the postdoc grant and the contract of the two authors.info:eu-repo/semantics/publishedVersio

Cabbage and fermented vegetables : From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

Large differences in COVID-19 death rates exist between countries and between regions of the same country. Some very low death rate countries such as Eastern Asia, Central Europe, or the Balkans have a common feature of eating large quantities of fermented foods. Although biases exist when examining ecological studies, fermented vegetables or cabbage have been associated with low death rates in European countries. SARS-CoV-2 binds to its receptor, the angiotensin-converting enzyme 2 (ACE2). As a result of SARS-CoV-2 binding, ACE2 downregulation enhances the angiotensin II receptor type 1 (AT(1)R) axis associated with oxidative stress. This leads to insulin resistance as well as lung and endothelial damage, two severe outcomes of COVID-19. The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is the most potent antioxidant in humans and can block in particular the AT(1)R axis. Cabbage contains precursors of sulforaphane, the most active natural activator of Nrf2. Fermented vegetables contain many lactobacilli, which are also potent Nrf2 activators. Three examples are: kimchi in Korea, westernized foods, and the slum paradox. It is proposed that fermented cabbage is a proof-of-concept of dietary manipulations that may enhance Nrf2-associated antioxidant effects, helpful in mitigating COVID-19 severity.Peer reviewe

Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies

There are large between- and within-country variations in COVID-19 death rates. Some very low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have a common feature of eating large quantities of fermented foods whose intake is associated with the activation of the Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) anti-oxidant transcription factor. There are many Nrf2-interacting nutrients (berberine, curcumin, epigallocatechin gallate, genistein, quercetin, resveratrol, sulforaphane) that all act similarly to reduce insulin resistance, endothelial damage, lung injury and cytokine storm. They also act on the same mechanisms (mTOR: Mammalian target of rapamycin, PPAR gamma:Peroxisome proliferator-activated receptor, NF kappa B: Nuclear factor kappa B, ERK: Extracellular signal-regulated kinases and eIF2 alpha:Elongation initiation factor 2 alpha). They may as a result be important in mitigating the severity of COVID-19, acting through the endoplasmic reticulum stress or ACE-Angiotensin-II-AT(1)R axis (AT(1)R) pathway. Many Nrf2-interacting nutrients are also interacting with TRPA1 and/or TRPV1. Interestingly, geographical areas with very low COVID-19 mortality are those with the lowest prevalence of obesity (Sub-Saharan Africa and Asia). It is tempting to propose that Nrf2-interacting foods and nutrients can re-balance insulin resistance and have a significant effect on COVID-19 severity. It is therefore possible that the intake of these foods may restore an optimal natural balance for the Nrf2 pathway and may be of interest in the mitigation of COVID-19 severity

Metabolipidomic profiling reveals an age- related deficiency of skeletal muscle pro- resolving mediators that contributes to maladaptive tissue remodeling

Specialized pro- resolving mediators actively limit inflammation and support tissue regeneration, but their role in age- related muscle dysfunction has not been explored. We profiled the mediator lipidome of aging muscle via liquid chromatography- tandem mass spectrometry and tested whether treatment with the pro- resolving mediator resolvin D1 (RvD1) could rejuvenate the regenerative ability of aged muscle. Aged mice displayed chronic muscle inflammation and this was associated with a basal deficiency of pro- resolving mediators 8- oxo- RvD1, resolvin E3, and maresin 1, as well as many anti- inflammatory cytochrome P450- derived lipid epoxides. Following muscle injury, young and aged mice produced similar amounts of most pro- inflammatory eicosanoid metabolites of cyclooxygenase (e.g., prostaglandin E2) and 12- lipoxygenase (e.g., 12- hydroxy- eicosatetraenoic acid), but aged mice produced fewer markers of pro- resolving mediators including the lipoxins (15- hydroxy- eicosatetraenoic acid), D- resolvins/protectins (17- hydroxy- docosahexaenoic acid), E- resolvins (18- hydroxy- eicosapentaenoic acid), and maresins (14- hydroxy- docosahexaenoic acid). Similar absences of downstream pro- resolving mediators including lipoxin A4, resolvin D6, protectin D1/DX, and maresin 1 in aged muscle were associated with greater inflammation, impaired myofiber regeneration, and delayed recovery of strength. Daily intraperitoneal injection of RvD1 had minimal impact on intramuscular leukocyte infiltration and myofiber regeneration but suppressed inflammatory cytokine expression, limited fibrosis, and improved recovery of muscle function. We conclude that aging results in deficient local biosynthesis of specialized pro- resolving mediators in muscle and that immunoresolvents may be attractive novel therapeutics for the treatment of muscular injuries and associated pain in the elderly, due to positive effects on recovery of muscle function without the negative side effects on tissue regeneration of non- steroidal anti- inflammatory drugs.Chronic low- grade inflammation of aging muscle was associated with a basal deficiency of maresin 1, resolvin E3, 8- oxo- resolvin D1, and anti- inflammatory fatty acid epoxides. Aged mice produced normal amounts of most prostaglandins following muscle injury but were deficient in local biosynthesis of markers of the lipoxins, E- resolvins, D- resolvins, and maresins. Systemic treatment with resolvin D1 suppressed inflammatory cytokine expression, limited muscle fibrosis, and improved functional recovery.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/168317/1/acel13393-sup-0002-TableS1.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/168317/2/acel13393-sup-0003-TableS2.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/168317/3/acel13393_am.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/168317/4/acel13393-sup-0001-FigS1-S4.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/168317/5/acel13393.pd

Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells

Specialized proresolving mediators (SPMs) actively limit inflammation and expedite its resolution by modulating leukocyte recruitment and function. Here we profiled intramuscular lipid mediators via liquid chromatography-tandem mass spectrometry–based metabolipidomics following myofiber injury and investigated the potential role of SPMs in skeletal muscle inflammation and repair. Both proinflammatory eicosanoids and SPMs increased following myofiber damage induced by either intramuscular injection of barium chloride or synergist ablation–induced functional muscle overload. Daily systemic administration of the SPM resolvin D1 (RvD1) as an immunoresolvent limited the degree and duration of inflammation, enhanced regenerating myofiber growth, and improved recovery of muscle strength. RvD1 suppressed inflammatory cytokine expression, enhanced polymorphonuclear cell clearance, modulated the local muscle stem cell response, and polarized intramuscular macrophages to a more proregenerative subset. RvD1 had minimal direct impact on in vitro myogenesis but directly suppressed myokine production and stimulated macrophage phagocytosis, showing that SPMs can modulate both infiltrating myeloid and resident muscle cell populations. These data reveal the efficacy of immunoresolvents as a novel alternative to classical antiinflammatory interventions in the management of muscle injuries to modulate inflammation while stimulating tissue repair

Use of Agro-Industrial Waste for Biosurfactant Production: A Comparative Study of Hemicellulosic Liquors from Corncobs and Sunflower Stalks

Biosurfactants have attracted considerable attention because of their lower toxicity, biocompatibility, and effectiveness over chemical surfactants. The use of renewable sources and the concept of sustainable production for such biomolecules supports the increased demand for eco-friendly products. Herein, the present study investigated corncobs (CC) and sunflower stalks (SS) as substitutes for conventional substrates in submerged fermentation with B. subtilis. The agro-industrial residues were submitted to an alkaline pretreatment to obtain hydrolysates rich in hemicelluloses, whose concentrations were determined at 48.8% and 65.7% for corncob and sunflower stalk liquors, respectively. The influence of different concentrations of glucose (0, 2.5, and 5%) and liquor (0, 20%, and 40%) were evaluated according to cell concentration, surface tension reduction rate (STRR), and emulsification index (EI24). Biosurfactants obtained with the hemicellulose liquor of sunflower stalk showed the highest cell concentration (4.57 g/L) and STRR (58.07%), whereas the maximum values of EI24 (56.90% in hexane, 65.63% in toluene, and 64.86% in kerosene) were achieved by using corncob liquor. All top results were observed at 2.5% glucose, 20% liquor (CC or SS), and 1% mineral salts. Notably, excess glucose or liquor (CC or SS) negatively affected cell growth and biosurfactant performance. The results indicated the potential of corncobs and sunflower stalks as low-cost substrates to produce a high added-value biosurfactant with promising tensoative and emulsifying properties

Assessment of Angiogenesis and Cell Survivability of an Inkjet Bioprinted Biological Implant in an Animal Model

The rapidly growing field of tissue engineering hopes to soon address the shortage of transplantable tissues, allowing for precise control and fabrication that could be made for each specific patient. The protocols currently in place to print large-scale tissues have yet to address the main challenge of nutritional deficiencies in the central areas of the engineered tissue, causing necrosis deep within and rendering it ineffective. Bioprinted microvasculature has been proposed to encourage angiogenesis and facilitate the mobility of oxygen and nutrients throughout the engineered tissue. An implant made via an inkjet printing process containing human microvascular endothelial cells was placed in both B17-SCID and NSG-SGM3 animal models to determine the rate of angiogenesis and degree of cell survival. The implantable tissues were made using a combination of alginate and gelatin type B; all implants were printed via previously published procedures using a modified HP inkjet printer. Histopathological results show a dramatic increase in the average microvasculature formation for mice that received the printed constructs within the implant area when compared to the manual and control implants, indicating inkjet bioprinting technology can be effectively used for vascularization of engineered tissues